Serum levels of retinol-binding protein 4 and the risk of non-small cell lung cancer: A case-control study

Retinol binding protein 4 (RBP4), as an adipokine, has been identified to be associated with several types of cancer. However, no studies have assessed its effect on non-small cell lung cancer (NSCLC) risk. The objective of this study was to assess the association between serum RBP4 levels and the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xiaoping, Huang, Wenjun, Wang, Feng, Dai, Yifei, Hu, Xiaocong, Yue, Daoyuan, Wang, Shaomin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402748/
https://www.ncbi.nlm.nih.gov/pubmed/32756103
http://dx.doi.org/10.1097/MD.0000000000021254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402748/
https://www.ncbi.nlm.nih.gov/pubmed/32756103
http://dx.doi.org/10.1097/MD.0000000000021254

Ejemplares similares